Current State of Hormone Replacement Therapy: The Case for Using Trimegestone | Zendy

May Wahab | Zendy; Farook AlAzzawi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current State of Hormone Replacement Therapy: The Case for Using Trimegestone

Author(s) -

May Wahab,

Farook AlAzzawi

Publication year - 2006

Publication title -

women s health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.363

H-Index - 39

eISSN - 1745-5065

pISSN - 1745-5057

DOI - 10.2217/17455057.2.4.539

Subject(s) - progestogen , estrogen , medicine , endometrial hyperplasia , uterus , hormone replacement therapy (female to male) , hormone therapy , estrogen replacement therapy , vasomotor , hormone , gynecology , physiology , hyperplasia , testosterone (patch) , breast cancer , cancer

Estrogen deficiency has a negative impact on the quality of life of postmenopausal women and is associated with vasomotor symptoms, insomnia and emotional lability. Other manifestations of estrogen deficiency include dry skin, dry vagina and dyspareunia, in addition to bone loss. Estrogen replacement effectively reverses these changes. The only indication for the administration of a progestogen is to protect the postmenopausal uterus against the potential development of endometrial hyperplasia and carcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research